FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989450242> ?p ?o ?g. }

• W2989450242 endingPage "2961" @default.
• W2989450242 startingPage "2961" @default.
• W2989450242 abstract "Myelofibrosis (MF) is characterized by constitutive activation of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway and progressive bone marrow (BM) fibrosis. We previously found that the BM fibrosis in MF is induced by clonal monocyte-derived fibrocytes. However, whether or how the JAK-STAT pathway affects MF fibrocyte differentiation and maturation has not been elucidated. A recent study suggested that the transcription factor glioma-associated oncogene homolog 1 (Gli1) plays a significant role in the induction of BM fibrosis in MF (Schneider et al. Cell Stem Cell 2017). We have recently found that MF BM fibrocytes express high levels of Gli1 both in situ and in vitro (ASH 2018: Abstract 1793). Therefore, we sought to determine whether Gli1 affects the differentiation and maturation of MF fibrocytes and whether Gli1 expression is induced by the constitutively activated JAK-STAT pathway. To test our hypothesis, we first cultured normal donor and MF patients' BM CD14+ monocytes in fibrocyte differentiation-supporting medium and then transfected them using Gli1-siRNA. After 14 days we quantitated the number of mature fibrocytes using F-actin and DAPI staining. We found that the numbers of BM monocyte-derived fibrocytes in cultures containing Gli1-siRNA were significantly lower compared to mock-transfected cells. To study downstream effects of Gli1 silencing, we transfected mature fibrocytes with Gli1-siRNA and found that the expression of Gli1 was reduced by 137-fold (P<0.0001) and that Gli1 protein level was significantly reduced as assessed by western immunoblotting. Then, to determine whether Gli1 affects the differentiation and function of BM fibrocytes we assessed the levels of matrix metalloproteinases (MMPs) 2 and 9, known to activate TGF-β that induces collagen expression in fibrocytes. Using magnetic bead-based flow immunoassay we found a 5.2-fold increase in the plasma levels of MMP-2 of 59 treatment-naïve MF patients compared to healthy donors (P<0.0001). Therefore we wondered whether Gli1 silencing downregulates expression of both MMP-2 and MMP-9 in MF patients' fibrocytes. Then, using quantitative PCR we detected 2.5- and 2.7-fold lower expression of both MMP-2 and MMP-9 genes in MF fibrocytes transfected with Gli1-siRNA (P=0.0006 and P=0.0018, respectively). These findings were further corroborated on the protein level using western blot analysis. Remarkably, unlike Gli1-siRNA, the Gli1 antagonist GANT61 did not change the expression of either MMP-2 or MMP-9, suggesting that this inhibitor acts through a Gli1-independent mechanism. Because JAK-STAT pathway is constitutively activated in MF patients' fibrocytes, we sought to determine whether Gli1 expression is induced by STAT3. Using sequence analysis we identified 5 putative STAT3-binding sites in the Gli1 gene promoter region and designed probes that target these sites. Using chromatin immunoprecipitation (ChIP) assay we found that STAT3 protein co-precipitated all 5 STAT3-putative binding sites at high affinity. Then, by performing an electromobility shift assay (EMSA) of the fibrocyte nuclear extracts using DNA probes against Gli1 gene promoter STAT3-binding sites we detected STAT3-Gli1 DNA complexes, suggesting that STAT3 binds to the Gli1 gene promoter. We further confirmed these findings using anti-STAT3 antibodies which significantly attenuated the binding. Finally, we transfected MF fibrocytes with STAT3-siRNA and found that STAT3 siRNA significantly decreased Gli1 mRNA levels. In conclusion, we found that STAT3, phosphorylated by constitutively activated JAK2, induces the expression of Gli1 which in turn promotes the differentiation and maturation of MF fibrocytes. Downregulation of Gli1 levels halted fibrocyte development, suggesting that inhibition of Gli1 might alleviate BM fibrosis in patients with MF. Disclosures Verstovsek: Incyte: Research Funding; Roche: Research Funding; NS Pharma: Research Funding; Celgene: Consultancy, Research Funding; Gilead: Research Funding; Promedior: Research Funding; CTI BioPharma Corp: Research Funding; Genetech: Research Funding; Blueprint Medicines Corp: Research Funding; Novartis: Consultancy, Research Funding; Sierra Oncology: Research Funding; Pharma Essentia: Research Funding; Astrazeneca: Research Funding; Ital Pharma: Research Funding; Protaganist Therapeutics: Research Funding; Constellation: Consultancy; Pragmatist: Consultancy." @default.
• W2989450242 created "2019-11-22" @default.
• W2989450242 creator A5008109253 @default.
• W2989450242 creator A5014362126 @default.
• W2989450242 creator A5037747480 @default.
• W2989450242 creator A5038702695 @default.
• W2989450242 creator A5051587942 @default.
• W2989450242 creator A5054484090 @default.
• W2989450242 creator A5056588391 @default.
• W2989450242 creator A5069614323 @default.
• W2989450242 creator A5084290698 @default.
• W2989450242 creator A5085521139 @default.
• W2989450242 date "2019-11-13" @default.
• W2989450242 modified "2023-09-26" @default.
• W2989450242 title "STAT3-Induced Gli1 Promotes the Differentiation and Maturation of Myelofibrosis Fibrocytes" @default.
• W2989450242 doi "https://doi.org/10.1182/blood-2019-132054" @default.
• W2989450242 hasPublicationYear "2019" @default.
• W2989450242 type Work @default.
• W2989450242 sameAs 2989450242 @default.
• W2989450242 citedByCount "0" @default.
• W2989450242 crossrefType "journal-article" @default.
• W2989450242 hasAuthorship W2989450242A5008109253 @default.
• W2989450242 hasAuthorship W2989450242A5014362126 @default.
• W2989450242 hasAuthorship W2989450242A5037747480 @default.
• W2989450242 hasAuthorship W2989450242A5038702695 @default.
• W2989450242 hasAuthorship W2989450242A5051587942 @default.
• W2989450242 hasAuthorship W2989450242A5054484090 @default.
• W2989450242 hasAuthorship W2989450242A5056588391 @default.
• W2989450242 hasAuthorship W2989450242A5069614323 @default.
• W2989450242 hasAuthorship W2989450242A5084290698 @default.
• W2989450242 hasAuthorship W2989450242A5085521139 @default.
• W2989450242 hasConcept C104317684 @default.
• W2989450242 hasConcept C105702510 @default.
• W2989450242 hasConcept C112392421 @default.
• W2989450242 hasConcept C148738053 @default.
• W2989450242 hasConcept C153911025 @default.
• W2989450242 hasConcept C2779933373 @default.
• W2989450242 hasConcept C502942594 @default.
• W2989450242 hasConcept C55493867 @default.
• W2989450242 hasConcept C62478195 @default.
• W2989450242 hasConcept C75786153 @default.
• W2989450242 hasConcept C86803240 @default.
• W2989450242 hasConcept C88498014 @default.
• W2989450242 hasConcept C95444343 @default.
• W2989450242 hasConceptScore W2989450242C104317684 @default.
• W2989450242 hasConceptScore W2989450242C105702510 @default.
• W2989450242 hasConceptScore W2989450242C112392421 @default.
• W2989450242 hasConceptScore W2989450242C148738053 @default.
• W2989450242 hasConceptScore W2989450242C153911025 @default.
• W2989450242 hasConceptScore W2989450242C2779933373 @default.
• W2989450242 hasConceptScore W2989450242C502942594 @default.
• W2989450242 hasConceptScore W2989450242C55493867 @default.
• W2989450242 hasConceptScore W2989450242C62478195 @default.
• W2989450242 hasConceptScore W2989450242C75786153 @default.
• W2989450242 hasConceptScore W2989450242C86803240 @default.
• W2989450242 hasConceptScore W2989450242C88498014 @default.
• W2989450242 hasConceptScore W2989450242C95444343 @default.
• W2989450242 hasIssue "Supplement_1" @default.
• W2989450242 hasLocation W29894502421 @default.
• W2989450242 hasOpenAccess W2989450242 @default.
• W2989450242 hasPrimaryLocation W29894502421 @default.
• W2989450242 hasRelatedWork W1942397261 @default.
• W2989450242 hasRelatedWork W1989313612 @default.
• W2989450242 hasRelatedWork W2078278486 @default.
• W2989450242 hasRelatedWork W2128670495 @default.
• W2989450242 hasRelatedWork W2178741632 @default.
• W2989450242 hasRelatedWork W2521458339 @default.
• W2989450242 hasRelatedWork W2771360086 @default.
• W2989450242 hasRelatedWork W2896604045 @default.
• W2989450242 hasRelatedWork W2989450242 @default.
• W2989450242 hasRelatedWork W3126072837 @default.
• W2989450242 hasVolume "134" @default.
• W2989450242 isParatext "false" @default.
• W2989450242 isRetracted "false" @default.
• W2989450242 magId "2989450242" @default.
• W2989450242 workType "article" @default.